A carregar...
Efficacy of Bevacizumab-Capecitabine in Combination for the First-Line Treatment of Metastatic Breast Cancer
There is an ongoing need for development of new chemotherapeutic regimens for metastatic breast cancer [mBC], especially when tumors lack therapeutic targets such as the estrogen or progesterone receptor [ER/PR], or the human epidermal growth factor receptor-2 [HER2]. Capecitabine is an orally bioav...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Libertas Academica
2011
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3235996/ https://ncbi.nlm.nih.gov/pubmed/22174585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/BCBCR.S7379 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|